The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...

In The Star's annual year in review, the county's biggest business stories included housing proposals and the aftermath of a ...

On December 19, 2025, the National Security Commission on Emerging Biotechnology (NSCEB) announced the publication of a paper entitled “The Future of U.S.-China Biotechnology Competition.” The paper ...

An announcement from Anbio Biotechnology Class A ( ($NNNN) ) is now available. On December 30, 2025, Anbio Biotechnology reported unaudited ...

Hong Kong Pharma Digital Technology Holdings Ltd. ( ($HKPD) ) has provided an update. At its annual general meeting on December 12, 2025, Cellyan ...

After a strong biotech rebound, one fund quietly walked away from sector beta, and the timing says more than the trade itself.

Adding another potential wrinkle to the industry’s work with China is the Biosecure Act, a piece of China-targeting national ...

Discover how intellectual property rights protect exclusive pharmaceutical use and brand names in biotechnology, influencing innovation and market dynamics.

Compare the 2026 BSc Microbiology and BSc Biotechnology. To help you choose between a career in genetic engineering and ...